A growing bloc of aerosol scientists, epidemiologists, and infectious disease experts are urging the World Health Organization to acknowledge that particles containing SARS-CoV-2, the virus that causes COVID-19, can remain suspended in the air for hours and be inhaled, potentially representing another route of transmission. Some 239 scientists from around the world urged the WHO […] Continue reading ->
Access to life-saving dexamethasone will be expanded to some 4.5 million COVID-19 patients in low- and middle-income countries through an advance bulk purchase of the drug in bulk, UNITAID has said. The move is the first concrete step by a global health agency under the umbrella of the WHO ACT accelerator partnership to boost access […] Continue reading ->
The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading ->
A landmark meeting hosted next week by the International Energy Agency (IEA) will bring together major powers to debate the key actions for a climate-friendly COVID-19 recovery in an online forum open to public viewing.  The IEA Clean Energy Transitions Summit will be live-streamed July 9th, and bring together the world’s largest economies and developing […] Continue reading ->
A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading ->